RecruitingPhase 3NCT06767514
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
Sponsor: Summit Therapeutics
Mullica Hill, NJ · New Brunswick, NJ · +95 more sites
Lung Cancer clinical trials in Mullica Hill, NJ
2 recruiting lung cancer studies with a site in Mullica Hill, NJ.
RecruitingPhase 2NCT06463665
Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer
Sponsor: Genelux Corporation
Mullica Hill, NJ · +14 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.